Tirzepatide is a cutting-edge, dual-action receptor agonist that targets both GLP-1 and GIP pathways. Designed exclusively for research purposes, this compound has shown significant promise in studies focused on weight loss and metabolic health.
Available in 10mg, 20mg, and 30mg strengths, Tirzepatide provides researchers with a flexible, high-impact tool for investigating advanced metabolic therapies.
⸻
🔬 Key Benefits
• Research Use Only: Not intended for clinical or human use.
• Dual Mechanism of Action: Simultaneous activation of GLP-1 and GIP receptors for amplified metabolic effects.
• Flexible Dosing Options: Choose from 10mg, 20mg, or 30mg vials to suit your study design.
• Ideal for Advanced Studies: Well-suited for research into obesity, type 2 diabetes, and related metabolic conditions.
• Free Injection Pen Included: Each order comes with a complimentary injection pen for convenient and precise dosing.
⸻
📦 Product Overview
• Form: Lyophilized peptide powder
• Storage: Store in a cool, dry place. After reconstitution, refrigerate at 2–8°C.
• Packaging: Securely sealed vials, shipped with a sterile injection pen and instructions.
⸻
🛒 Now Available
Order Tirzepatide in 10mg, 20mg, or 30mg vials — each including a free injection pen.
